triiodothyronine has been researched along with Bowel Diseases, Inflammatory in 5 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Bertani, L | 3 |
Tricò, D | 3 |
Pugliese, D | 2 |
Privitera, G | 1 |
Linsalata, G | 1 |
Zanzi, F | 1 |
Gloria Mumolo, M | 1 |
Barberio, B | 1 |
Monzani, F | 1 |
Marchi, S | 1 |
Guidi, L | 1 |
Blandizzi, C | 2 |
Armuzzi, A | 1 |
Costa, F | 2 |
Carbery, I | 1 |
Selinger, CP | 1 |
Paschou, SA | 1 |
Palioura, E | 1 |
Kothonas, F | 1 |
Myroforidis, A | 1 |
Loi, V | 1 |
Poulou, A | 1 |
Goumas, K | 1 |
Effraimidis, G | 1 |
Vryonidou, A | 1 |
5 other studies available for triiodothyronine and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue.
Topics: Biomarkers; Humans; Inflammatory Bowel Diseases; Thyroxine; Triiodothyronine | 2022 |
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.
Topics: Aged; Biological Therapy; Humans; Inflammatory Bowel Diseases; Middle Aged; Thyroxine; Treatment Out | 2021 |
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply.
Topics: Aged; Biological Products; Biological Therapy; Humans; Inflammatory Bowel Diseases; Thyroxine; Treat | 2021 |
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD?
Topics: Aged; Biological Products; Biological Therapy; Humans; Inflammatory Bowel Diseases; Thyroxine; Treat | 2021 |
The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Gastrointestinal A | 2018 |